Interestingly, the ability of TRIM28 to enhance the malignancy of breast cancer cells transpires in part through its transcriptional repression of both p21 and gadd45a15,16,18, two transcripts whose expression is negatively regulated by BORG in D2.OR cells (Fig. 4b). This evidence concerns the gene CDKN1A and breast carcinoma.